| Title: | High threshold of beta 1 integrin inhibition required to block collagen I-induced membrane type-1 matrix metalloproteinase (MT1-MMP) activation of matrix metalloproteinase 2 (MMP-2) |
| Authors: | Borrirukwanit, K Pavasant, P Blick, T Lafleur, MA Thompson, EW |
| Issue Year: | 2014 |
| Publisher | BIOMED CENTRAL LTD |
| Series | CANCER CELL INTERNATIONAL: 14(): - |
| Abstract | Background: Matrix metalloproteinase-2 (MMP-2) is an endopeptidase that facilitates extracellular matrix remodeling and molecular regulation, and is implicated in tumor metastasis. Type I collagen (Col I) regulates the activation of MMP-2 through both transcriptional and post-transcriptional means; however gaps remain in our understanding of the involvement of collagen-binding beta 1 integrins in collagen-stimulated MMP-2 activation. Methods: Three beta 1 integrin siRNAs were used to elucidate the involvement of beta 1 integrins in the Col I-induced MMP-2 activation mechanism. beta 1 integrin knockdown was analyzed by quantitative RT-PCR, Western Blot and FACS analysis. Adhesion assay and collagen gel contraction were used to test the biological effects of beta 1 integrin abrogation. MMP-2 activation levels were monitored by gelatin zymography. Results: All three beta 1 integrin siRNAs were efficient at beta 1 integrin knockdown and FACS analysis revealed commensurate reductions of integrins a2 and a3, which are heterodimeric partners of beta 1, but not aV, which is not. All three beta 1 integrin siRNAs inhibited adhesion and collagen gel contraction, however only the siRNA showing the greatest magnitude of beta 1 knockdown inhibited Col I-induced MMP-2 activation and reduced the accompanying upregulation of MT1-MMP, suggesting a dose response threshold effect. Re-transfection with codon-swapped beta 1 integrin overcame the reduction in MMP-2 activation induced by Col-1, confirming the beta 1 integrin target specificity. MMP-2 activation induced by TPA or Concanavalin A (Con A) was not inhibited by beta 1 integrin siRNA knockdown. Conclusion: Together, the data reveals that strong abrogation of beta 1 integrin is required to block MMP-2 activation induced by Col I, which may have implications for the therapeutic targeting of beta 1 integrin. |
| URI: | https://publications.svi.edu.au/publications/1765 |
| Other Identifiers | 10.1186/s12935-014-0099-3 |
| Publication type | Article |
| Find it online | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195858/ |